Document Detail

Attenuation of ischemic myocardial injury and dysfunction by cardiac fibroblast-derived factor(s).
MedLine Citation:
PMID:  21485651     Owner:  NLM     Status:  In-Process    
Fibroblasts, the majority of non-cardiomyocytes in the heart, are known to release several kinds of substances such as cytokines and hormones that affect cell and tissue functions. We hypothesized that undefined substance (s) derived from cardiac fibroblasts may have the potential to protect against ischemic myocardium. To assess our hypothesis, using rats, we investigated: (1) the effect of cardiac fibroblast-conditioned medium (CM) on the viability of hypoxic cardiomyocytes in vitro, (2) the effect of CM on left ventricular (LV) function in global ischemia-reperfusion in an ex vive model, (3) the mechanism underlying cardioprotection by CM. Seventy-two hours after starting a hypoxic culture, the viability of cardiomyocytes was higher (P < 0.05) in the CM treated group (41.4%) compared to the control (20.5%). In Langendorff's preparation, 30 min after ischemia-reperfusion, LV end-diastolic pressure was lower, and LV developed pressure and -LVdP/dt were higher (P < 0.01 or P < 0.05) in the CM group than in the control, although coronary flow did not differ between the two groups. Pretreatment with a protein kinase C inhibitor or a mitochondrial ATP-sensitive K+ channel blocker attenuated these changes of LV function in the CM group. Such cardioprotection was achieved by a fraction of the CM having a molecular weight (MW) > 50,000, but not by that of the CM with a lower MW. In addition, a specific antibody against hepatocyte growth factor (HGF, MW is 84,000) did not reduce the cardioprotection afforded by CM. There may be an unknown cardioprotective substance other than HGF in rats, which mimics ischemic preconditioning and has MW > 50,000.
Kazuhiko Nakazato; Wakako Naganuma; Kazuei Ogawa; Hiroyuki Yaoita; Shinya Mizuno; Toshikazu Nakamura; Yukio Maruyama
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Fukushima journal of medical science     Volume:  56     ISSN:  0016-2590     ISO Abbreviation:  Fukushima J Med Sci     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2011-04-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374626     Medline TA:  Fukushima J Med Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1-16     Citation Subset:  IM    
Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Improving quality in care homes using an electronic tool.
Next Document:  No inhibitory effects of (-)-epigallocatechin gallate and lycopene on spontaneous hepatotumorigenesi...